These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34118482)

  • 1. Clinical and epidemiological features of patients colonised by different types of carbapenemase-producing Enterobacterales.
    Assis R; Lasnoy M; Adler A
    J Glob Antimicrob Resist; 2021 Sep; 26():108-113. PubMed ID: 34118482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenemase-producing Eenterobacterales from hospital environment and their relation to those from patient specimens.
    Kim SH; Kim GR; Kim EY; Jeong J; Kim S; Shin JH
    J Infect Public Health; 2022 Feb; 15(2):241-244. PubMed ID: 35065356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of and Risk Factors for Subsequent Carbapenemase-producing Enterobacterales (CPE) Bacteraemia in Rectal CPE Carriers.
    Kang SW; Park S; Kim AR; Han J; Lee J; Seo H; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    Int J Antimicrob Agents; 2023 Nov; 62(5):106959. PubMed ID: 37633425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
    Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
    J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13.
    Adler A; Hussein O; Ben-David D; Masarwa S; Navon-Venezia S; Schwaber MJ; Carmeli Y;
    J Antimicrob Chemother; 2015 Jan; 70(1):89-92. PubMed ID: 25204343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay.
    Song W; Park MJ; Jeong S; Shin DH; Kim JS; Kim HS; Kim HS; Lee N; Hong JS; Jeong SH
    Ann Lab Med; 2020 May; 40(3):259-263. PubMed ID: 31858767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of OXA-48-producing Enterobacterales in a haematological ward associated with an uncommon environmental reservoir, France, 2016 to 2019.
    Jolivet S; Couturier J; Vuillemin X; Gouot C; Nesa D; Adam M; Brissot E; Mohty M; Bonnin RA; Dortet L; Barbut F
    Euro Surveill; 2021 May; 26(21):. PubMed ID: 34047273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
    Dickstein Y; Solter E; Schwartz D; Nutman A; Harevrich I; Wulffhart L; Carmeli Y; Schwaber MJ
    Clin Microbiol Infect; 2021 Oct; 27(10):1518.e1-1518.e3. PubMed ID: 34111587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Disk carbapenemase test using improved disks for rapid detection and differentiation of clinical isolates of carbapenemase-producing Enterobacterales.
    Lee H; Kim JL; Jung DH; Seo Y; Kim M; Yong D; Lee K; Chong Y
    J Infect Chemother; 2021 Aug; 27(8):1205-1211. PubMed ID: 33888420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection.
    Temkin E; Solter E; Lugassy C; Chen D; Cohen A; Schwaber MJ; Carmeli Y;
    Clin Infect Dis; 2024 Jul; 79(1):22-29. PubMed ID: 38447961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital.
    Aquino-Andrade A; Merida-Vieyra J; Arias de la Garza E; Arzate-Barbosa P; De Colsa Ranero A
    BMC Microbiol; 2018 Apr; 18(1):38. PubMed ID: 29673319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of carbapenemase-producing
    Hopkins KL; Ellaby N; Ellington MJ; Doumith M; Mustafa N; Meunier D; Woodford N
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35604946
    [No Abstract]   [Full Text] [Related]  

  • 18. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
    Sidjabat HE; Townell N; Nimmo GR; George NM; Robson J; Vohra R; Davis L; Heney C; Paterson DL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4059-66. PubMed ID: 25918153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study.
    Seo H; Kim HJ; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Jung J
    Clin Microbiol Infect; 2021 Aug; 27(8):1167.e1-1167.e8. PubMed ID: 33010443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.